As of October 2024, Matinas BioPharma Holdings has a market cap of $764.77M. This makes Matinas BioPharma Holdings the world's 9090th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $48.21M | 2.73% |
2023 | $46.93M | -56.80% |
2022 | $108.63M | -50.50% |
2021 | $219.44M | -25.74% |
2020 | $295.48M | -40.09% |
2019 | $493.19M | 281.51% |
2018 | $129.27M | -48.71% |
2017 | $252.03M | -17.14% |
2016 | $304.17M | 64.71% |
2015 | $184.68M | 88.89% |
2014 | $97.77M | - |